EZH2 and myelodysplastic syndrome: We tested this hypothesis for the EZH2 gene by determining the methylation status of 11 CpGs located in the promoter region by pyrosequencing in 11 MDS/AML patients with loss of one EZH2 allele and 49 patients that were diploid for this gene by cytogenetics or FISH analyses.